In clinical settings, measuring cTnI levels in blood is a standard procedure for diagnosing acute myocardial infarction. Elevated cTnI levels indicate cardiac muscle injury, which can be due to ischemic events, myocarditis, or other forms of cardiomyopathy. Moreover, monitoring cTnI levels over time can help evaluate the effectiveness of treatments and predict patient outcomes.